chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting in the late evening of the first day and extending to the second-day chills, fatigue,  and fever.  Today, the fourth day, my face is hot to the touch and skin is blotchy with eyes burning.
About 15 after the injection I felt flushed and developed a splotchy "rash" on my chest and stomach.  "Rash" only lasted about 15-20 min then went away. Then later on that day I started experiencing extreme all over body aches, headache, even my skin and hair hurt.  Could not sleep for 2 nights due to extreme pain and it also felt like I had restless leg at nights. Nausea. I  alternated Tylenol & Advil but neither helped.  Body ache symptoms started approx 8 hours after injection and lasted a total of approx 48 hours from injection.
Patient reported swelling on his upper arm. The inflammation has spread from the vaccination site to the front and back of the upper part of the arm. His arm did not show any redness, but patient reported pain and tenderness.
Information has been received from a pharmacist via field representative referring to an 86 year old female patient. Patients medical history, concurrent conditions and drug reactions/allergies were not reported. On 15-AUG-2015, the patient was vaccinated with PNEUMOVAX23 (strength, dose, frequency, route, lot #, expiry date unspecified). No concomitant medications were reported. Reporting physician stated that the patient developed pneumonia on an unspecified date in 2015, after she receiving the PNEUMOVAX23 (vaccination failure). Patient sought medical attention and called the pharmacist on an unknown date. Outcome of the events were unknown. Reporting pharmacist did not assessed the causality of the events with respect to vaccination with PNEUMOVAX23. Additional information has been requested.
His Parkinson's rigidity increased within a day or two, causing inability to work effectively, cannot type, had to increase routine medications.  He is now six months later with no resolution
The case was received on 21 March 2014. Initial misuse report received from a healthcare professional on 17 October 2013. A patient had received 0.5 ml dose of FLUZONE on an unspecified date. It was reproted that when injected, the needle separated and the patient did not get the full dose. No adverse event was reported. List of documents held by sender: none.
Patient was recently diagnosed with COVID-19 infection and presented with complaints of increasing shortness of breath, cough, and feeling unwell; treated with empiric antibiotics with Rocephin, Zithromax, Decadron steroids, vitamins D, C, and zinc, and did receive 5 days of remdesivir.  Patient's symptoms improved; therefore, patient was discharged home after 4 days of treatment here.
Initial report received from consumer's mother on 19 November 2013. The male patient received FLUZONE (lot number and expiration date unknown) intramuscularly in left deltoid (dose number not reported) about eight days ago and 24 hours after vaccination began experiencing headache and generalized muscle aches. The headache ws resolved but generalized muscle aches continue to today (19-Nov 2013). The patient took TYLENOL, ALEIVE. The patient's lab work was done. Documents held by sender: none.
She got her vaccine, had no AE.  Later on that day she had severe leg cramps, more intense than a Charlie horse.  She tried to do extensions of her foot and rub her legs, which helped a little.  It would go away and usually about say 40 minutes later they reoccurred.  These reactions lasted for about 5 hours on and off, then they subsided, and has had just the typical reactions at the injection site, redness, tenderness and back pain.
Dizziness; spinning; Dizziness; spinning; threw up; Stomach was upset; Stomach was queasy; This spontaneous case was reported by a patient and describes the occurrence of the first episode of DIZZINESS (Dizziness), the first episode of VERTIGO (spinning), ABDOMINAL DISCOMFORT (Stomach was upset), the second episode of DIZZINESS (Dizziness) and the second episode of VERTIGO (spinning) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach was upset) and NAUSEA (Stomach was queasy). On 18-Apr-2021, the patient experienced the first episode of DIZZINESS (Dizziness), the first episode of VERTIGO (spinning) and VOMITING (threw up). On 01-May-2021, the patient experienced the second episode of DIZZINESS (Dizziness) and the second episode of VERTIGO (spinning). On 18-Apr-2021, VOMITING (threw up) had resolved. On 01-May-2021, last episode of DIZZINESS (Dizziness) and the last episode of VERTIGO (spinning) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (Stomach was upset) and NAUSEA (Stomach was queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient reported that twelve days after receiving the vaccine, the patient was feeling dizzy, spinning, and she threw up. The patient also stated that her stomach was queasy and upset for a month since she had the vaccine.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: No new information was provided.
Patient is a 17-year-old, female. Alert, oriented X3, clear speech, able to answer to the questions. No known underlying medical conditions. No history of allergies. Denied having allergies to food, other vaccines, or components of COVID-19 vaccine. At 1:52 pm, the patient received her first dose of Pfizer (lot number EW0162, expires on 07/2021) on left deltoid, given by RN. Patient continued to be A&Ox3, walked herself over to the EMT waiting area with a steady, balanced, and sat down. At 2:10 pm, while waiting in observation area, patient reported feeling "light-headed" and ?tightness? in throat to her father. The patient?s father alerted EMTs of his daughter?s symptoms. EMT responded by offering the client a water bottle, assisting her to anti-gravity chair, and taking the patient's vitals. At 2:15 pm, BP 128/78, HR 66, Resp 14. Patient states the last time she ate was at 11:00 am, when she had a bagel and a cup of coffee. EMT alerted Lead RN of patient?s symptoms. Vial signs were taken every 5 minutes. At 2:20 pm, BP 126/80, Sp02 at 99% room air, HR 69bpm, Resp 16/min. At 2:25 pm, BP 126/80, HR 75 bpm, 17 resp/minute, unlabored. Patient still reporting lightheaded-ness and states ?it feels like I swallowed something when I breathe in?. At 2:30 pm, BP 117/78, HR 53, RR 14 res/min, unlabored, SpO2 99%. Patient reports tightness in throat ?feels better?. Patient and father were provided with education related to the use of Diphenhydramine for symptoms of allergic reaction. RN advised patient and father that if the tightness in throat worsens, to take Benadryl and notify health care provider. Patient and father were provided with education concerning when to call 9-1-1, including worsening of symptoms and trouble breathing. At 2:40 pm, BP 120/74, SpO2 98%, HR 74 bpm, RR 15 res/min, unlabored. Patient ingested 16 oz of water, denied any discomfort. Patient denies lightheadedness. At 10:45 pm, BP 123/80, HR 69, RR 16 res/min, unlabored, SpO2 99%. Patient left facility at 2:50 pm, accompanied by father to car. Patient denies dizziness and lightheadedness Patient was able to walk without assistance, gait was steady and balanced. Patient's father stated he would be driving her home.
24NOV97 devel pain & weakness rt leg also included rt shoulder & neck;26NOV97 pt seen by MD who sent pt to ER-adm to hosp;2DEC97 dx GBS miller-fisher variance;8DEC97 double vision & inc reflexes;weakness arm & eyelid;dx bells palsy 16JUL97
cannot remember if they received vaccine; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 4 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, the patient could not remember if received shingrix vaccine 4 years ago and the provider did not have any record. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked Would it be safe to repeat the two dose series.
Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose; Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch nos. 056M21A and 032M20M) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 27-Apr-2022, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2022, the patient experienced UNDERDOSE (Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022). At the time of the report, UNDERDOSE (Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No symptoms were reported after receipt of the Moderna COVID-19 vaccine.   No additional doses, medications, or treatments have been administered.
Generalized seizure - Taken to ER by EMS. Temp taken by mom during episode - 99.2 and 98.9.
Vaccine was given to 15 year old female patient in error (age not within approval). No symptoms or AEs per pt.
Symptoms started 3 days after her vaccine, and she reports having "inflammation" of various areas of her body.  She has breast cancer and had lumpectomy surgery on the L breast in Oct 2020.  She notes that her breast surgery site got very tender to palpation, felt some lumps there that were very tender, as if she had just had surgery.  She also had a headache, described as dull pain on the top of her head.  This then turned into a squeezing feeling in the head with stiff neck.  Other symptoms include: her jaw felt stiff (was difficult to open/close), had various muscle spasms in her body, such as on the front of her foot or in her rib cage, felt stabbing pains of the R breast and in her chest.
Onset 18NOV w/URI, sore throat, asthmatic MD prescribed E Mycin
rash developed after 10 days on neck, back, waist, under arms, forearms, back of knees. very itchy.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 59-year-old male patient received BNT162b2 (BNT162B2), on 08Apr2021 as dose 2, single (Lot number: EW0162) at the age of 59 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 1,  Unknown, Lot: EN6204, Expiration: Unknown, Dose given: Unknown, Time given: Unknown, Anatomical location: Left arm), administration date: 18Mar2021, when the patient was 59-year-old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 08Apr2021, outcome "not recovered", described as "Series or bunch of swollen lymph nodes popped up after the second vaccine/find another option instead of having walnuts in his arms and neck". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient had received the 3 covid vaccines, over the past 1.5 years. He had a series or a whole bunch of swollen lymph nodes which popped up at the 2nd vaccine." He has been tested and had a PET scan that revealed no cancer but he still had a multitude of swollen nodes, and he believed they were linked to the vaccine. He was looking for a solution.He was looking for treatment options. He noted that the doctors "were scratching their head at this point and did not know what to do other than cut him open and pull lymph nodes out" which he did not think it was a good alternative.
my arm itches; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (my arm itches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (my arm itches). At the time of the report, PRURITUS (my arm itches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
Pt received second dose Moderna vaccine 21 days after first dose t/c to patient 5/19/2021 at 4pm to inform patient of error.  Pt. states no adverse reaction noted.  Denies shortness of breath, denies lightheadedness, denies lethargy, denies muscle soreness in left arm.  Pt. advised to notify asap with signs & symptoms reverse reaction.  Pt. advised to call 911 if she has shortness of breath and/or feels tightening in throat.  Pt. verbalizes understanding.
When giving the flu shot in the left arm everything was fine, and when i gave the Typhim vaccine in the right arm everything was fine until I gave the 3rd vaccines the Twinrix in the right arm she went very limp and started to slide down the chair, she was nonresponsive and started to shake, I called for my pharmacist when she got there the patient was coming back to it. I asked her if she was okay, she was talking and answering all my questions. We gave her water and put a cold rag on the back of her neck.  Had her stay seated for about 15 mins she said she felt better i checked her heart rate and it was at 79 which she said was normal for her. i called her about and hour after and she said she was feeling okay. she stated she never had a reaction to any vaccines before.
Pt complains of flu like symptoms of body ache muscle cramps and joint pain with headache and gi cramp but no shortness of breath, rash or weakness or syncope symptoms started 18 hours after vaccination
This spontaneous report as received from a healthcare worker refers to a 64 year old female patient. The patient was vaccinated subcutaneously in unspecified arm with 0.65 ml ZOSTAVAX (lot number 672675/0068AE, expiration date 12-SEP-2013) on 27-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. Three days later, on approximately 30-AUG-2012 the patient experienced a "huge water blister the size of a lemon, at the injection site". The outcome of adverse event was reported as recovered. The patient called for office medical attention. Additional information has been requested. This is one of several reports received from the same source.
The vaccinator was injecting the patient with the vaccine whe the needle set started leaking at the base of the needle. When the vaccinator went to retract the needle to evaluate, the needle separated from the syringe and remained in the patient's arm. The needle was removed and the patient remained with issue.
Started this morning Fever tmax 101.2F, chills, fatigue, and headache. Tx with Motrin 400mg at 0800.
Developed "moderna arm" (raised inflammation with itching 1.5-2 inches long and 0.5-1 inches across) 7 days post vaccination from injection 1.   Developed somewhat severe tension headache on day 1 post vaccination from injection 2 (all further events listed below are from injection 2). Headache responded to ibuprofen.  On day 4 post vaccination, began experiencing minor and infrequent migraine-like headaches that lasted for a few seconds to a minute. Moderate pain and localized. Pain site changed but was generally on left side. Experienced 0-2 a day until day 12.  On day 11 post vaccination, began experiencing full, moderate tension headache. In addition, had more frequent migraine-like headaches. Did not respond to 400mg ibuprofen or 10mg Claritin.  On day 12 post vaccination, began experiencing photophobia. Mentioned to general practitioner out of an abundance of caution who recommended Excedrin. Took two Excedrin extra strength (total dosage: Acetomenaphin 500mg, Aspirin 500 mg, Caffeine 130 mg). Tension headache ended and most (but not all) migraine-like pain subsided. Some occasional pain ranging from 1-2 out of 10.  On day 13 out of an abundance of caution following reports of other events I went to the ER. The doctor there examined for any cognitive symptoms (asked me to follow her finger with my eyes, squeeze fingers, checked ability to move extremities, etc) and concluded no risk of CVST. Determined that vaccine likely lowered my threshold for headaches and migraines (I have had very infrequent cluster headaches lasting for a few seconds in the past, never for this duration). Final diagnosis was migraines. Doctor prescribed Fioricet and gave me a long-acting steroid. Some pain is still there, but symptoms have mostly stopped. Waves of quick bursts of pain on localized areas on the left side of my head are still occuring.
Information has been received from a health professional concerning a 34 month old pt who on 19Aug03 was vaccinated with a dose of varicella virus vaccine live (644558/1156M). Subsequently the pt experienced breakthrough. On 14Jul05 the child developed a rash that looked like bug bites. There were 100+ vesicular lesions. Unspecified medical attention was sought. Treatment was calamine lotion, baking soda baths and diphenhydramine hydrochloride (Benadryl). At the time of the report the pt was recovering. There was no product quality compliant involved. Additional information has been requested.
pt. experiencing a "scratchy" throat.  pt. denies any difficulty swallowing and/or any others s/p.  pt. able to take small sips of water.  medic present.  pt. monitored & symptoms resolved prior to leaving.   13:44/- 139/70; 69/ 96%/ 16
Patient received Pfizer at another pharmacy, thought she received Moderna and reported to us that she received Moderna. She had misplaced her CDC card. After receiving shot, patient found CDC card and realized her first dose was Pfizer.
Hospitalized with agitation and increased confusion (with neurocognitive disorder) cough, with phlegm production. treated with Remdesivir
Rash noted around site of VARIVAX injection. Started 3 day after injection, has spread. Area is irregular, with erythematous macular area and some well defined papular lesions, about 1 1/2" x 1 1/2", right thigh not swollen, itchy or tender. Patient seen in office 4/30/15.
Slowly developed swelling redness in a 4"x6" area-left arm at injection site.
Started out with a small rash at the injection site about the size of a quarter. Two days later it was about 2" X 4" in size and was more of a welt then a rash. The next day it was about 3" X 6".. Today it is down to her elbow. It does appear that it is starting to get better.
Swelling in the joints; Pain in joints; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swelling in the joints) and ARTHRALGIA (Pain in joints) in a 120-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0128AZIA and 043B2IA) for COVID-19 vaccination.     Concomitant products included FINASTERIDE, ARIPIPRAZOLE (ABILIFY) and SERTRALINE for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced JOINT SWELLING (Swelling in the joints) and ARTHRALGIA (Pain in joints). The patient was treated with IBUPROFEN for Joint pain, at a dose of 1 dosage form. At the time of the report, JOINT SWELLING (Swelling in the joints) and ARTHRALGIA (Pain in joints) outcome was unknown.
negative titer; rash at the injection site; This spontaneous report as received from a physician referring to a 20-year-old female patient. The patient's medical history, concomitant medications, drug allergies, or reactions were not reported.       On an unspecified date,  the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis (dose, frequency, administration route, lot number and expiry date were not reported) .  On an unknown day reported as recent, the patient performed a test that showed  negative titers so on 13-OCT-2021, she received a dose of  varicella virus vaccine live (oka/merck)(VARIVAX) booster  and she experienced vaccination site rash.    The outcome of antibody test negative and vaccination site rash was unknown.  and the reporter did not assess the causal relatedness between the events and the suspect vaccine.
pt recvd vax;by following day, devel large reddened area at inject site;
crying, fever 104 next day saw MD started on Phenobarb x 3 days;didn't sleep good; restless & crying;
12:30 - Received J&J vaccine 13:00 - Started to experience lip/gum tingling and chest tightness. Given Benadryl 50 mg PO x 1 in vaccine clinic. Symptoms progressed to throat tingling, coughing, difficulty swallowing, lightheadedness, some SOB.  13:15 - Transported to ED. Received IM Epi x 1; improved within a few minutes. Also received methylprednisolone, famotidine, IVF.  19:00 - Monitored in ED. Discharged home with Epi pen, prednisone, famotidine, Benadryl.
1/3 - 1/2 of dose spurted out of arm after needle withdrawn.
pt recv vax & 1 day later devel inj site rxn of cellulitis. This is 1 of 5 pt to exp rxn w/lot #449578
This case was reported by a consumer via out of hour services and described the occurrence of flu like symptoms in a female patient who received SHINGRIX for prophylaxis. On 12th June 2018, the patient received SHINGRIX. On 12th June 2018, less than a day after receiving SHINGRIX, the patient experienced flu like symptoms. On an unknown date, the outcome of the flu like symptoms was unknown. It was unknown if the reporter considered the flu like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient also reported that she was a GSK employee, via after hours voice mail (AHVM).
Pt reported no redness, but intense pain and some swelling starting 8 hours after immunization. Unable to move arm w/o pain; however recovering daily.
About 5 days after first dose, injection site developed an itchy rash. Rash is not uniform and has a more oval, oblong shape with more redness/rash at the bottom and a defined ring.